loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2430355 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN (1)

    filter

    01 SANOFI-AVENTIS CANADA INC (1)

    filter

    01 KIT (1)

    filter

    01 3000UNIT/VIAL (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Antihemophilic Factor (recombinant Bdd), Fc Fusion Protein

    PDF Supplier PDF
    URL Supplier Web Content
    KIT
    3000UNIT/VIAL
    ELOCTATE
    Canada
    2430355
    3ML
    Schedule D
    Sanofi Company Banner

    Cophex 2024

    Not Confirmed

    envelop Contact Supplier

    Looking for CTD TGA MCC DOSSIER APPLICATION 2430355

    Looking for CTD TGA MCC DOSSIER APPLICATION 2430355 1

    19

    Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    One of their notable products is ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN, with a corresponding application number 2430355 and regulatory information .

    proudly manufactured in the

    Sanofi's ELOCTATE KIT, medication with 3000UNIT/VIAL of ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN.

    Post Enquiry
    POST ENQUIRY